netFormulary
 Report : A-Z CDF items in Formulary 17/06/2021 20:27:39
[Back]
 
Section Status Homecare Name
10.01.03 Formulary Homecare Abatacept 
01.05.03 Formulary Homecare Adalimumab 
10.01.03 Formulary Homecare Adalimumab 
13.05.03 Formulary Homecare Adalimumab 
13.05.01 Formulary Homecare Alitretinoin 
10.01.03 Formulary Homecare Apremilast rheumatology
13.05.03 Formulary Homecare Apremilast Dermatology
10.02 Formulary Homecare Ataluren 
10.04 Formulary Homecare Ataluren 
10.01.03 Formulary Homecare Baricitinib 
13.05.03 Formulary Homecare Brodalumab Dermatology
06.07.02 Restricted Use Homecare Buserelin 
08.03.04.02 Formulary Homecare Buserelin 
10.01.03 Formulary Homecare Certolizumab Pegol 
13.05.03 Formulary Homecare Certolizumab pegol 
09.05.01.02 Formulary Homecare Cinacalcet 
09.01.03 Formulary Homecare Darbepoetin Alfa Aranesp
09.01.03 Formulary Homecare Deferasirox Exjade
08.02.04 Formulary Homecare Dimethyl fumarate Tecfidera
08.01.05 Formulary Homecare Dupilumab 
09.01.04 Formulary Homecare Eltrombopag 
09.01.03 Formulary Homecare Epoetin alfa Eprex
10.01.03 Formulary Homecare Etanercept Rheumatology
13.05.03 Formulary Homecare Etanercept 
08.02.04 Non Formulary Homecare Fampridine 
08.02.04 Formulary Homecare Glatiramer Acetate Copaxone
01.05.03 Formulary Homecare Golimumab Gastroenterology
10.01.03 Formulary Homecare Golimumab 
13.05.03 Formulary Homecare Guselkumab dermatology
06.05.01 Restricted Use Homecare Human Menopausal Gonadotrophins Menopur
08.02.04 Formulary Homecare Interferon Beta Avonex
08.02.04 Formulary Homecare Interferon Beta Rebif
08.02.04 Formulary Homecare Interferon Beta Betaferon
08.02.04 Formulary Homecare Interferon beta Extavia
13.05.03 Formulary Homecare Ixekizumab dermatology
08.01.05 Formulary Homecare Lorlatinib 
10.01.03 Formulary Homecare Methotrexate s/c rheumatology
08.02.01 Formulary Homecare Mycophenolic acid Myfortic
08.02.04 Formulary Homecare Natalizumab Tysabri
08.02.04 Formulary Homecare Peginterferon Beta-1a Plegridy
08.02.02 Formulary Homecare Prednisolone 
06.04.01.02 Restricted Use Homecare Progesterone Cyclogest
13.05.03 Formulary Homecare Risankizumab Dermatology
09.01.04 Formulary Homecare Romiplostim 
10.01.03 Formulary Homecare Sarilumab 
10.01.03 Formulary Homecare Secukinumab Rheumatology
13.05.03 Formulary Homecare Secukinumab 
08.02.04 Non Formulary Homecare Siponimod Mayzent
08.02.02 Formulary Homecare Sirolimus Rapamune
05.03.03.02 Formulary Homecare Sofosbuvir Sovaldi
05.03.03.02 Formulary Homecare Sofosbuvir and Velpatasvir Epclusa
06.05.01 Formulary Homecare Somatropin 
08.02.02 Formulary Homecare Tacrolimus Prograf
08.02.02 Formulary Homecare Tacrolimus Modigraf
08.02.02 Formulary Homecare Tacrolimus  AdoPORT
08.02.02 Formulary Homecare Tacrolimus Advagraf
06.06.01 Formulary Homecare Teriparatide 
13.05.03 Formulary Homecare Tildrakizumab Dermatology
10.01.03 Formulary Homecare Tocilizumab 
01.05.03 Formulary Homecare Tofacitinib Gastroenterology
10.01.03 Formulary Homecare Tofacitinib citrate 
10.01.03 Formulary Homecare Upadacitinib 
01.05.03 Formulary Homecare Ustekinumab Gastroenterology
10.01.03 Formulary Homecare Ustekinumab rheumatology
13.05.03 Formulary Homecare Ustekinumab 
Shropshire and Telford Local Health Economy